An overview of peripheral neuropathy in diabetes

Vascular Disease Management

Volumn 6, Issue 3, 2009, Pages 68-71

  Sheehan, Peter ^a  

^a Sheehan Health Management Corp   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; ANTICONVULSIVE AGENT; CARBAMAZEPINE; DESIPRAMINE; DULOXETINE; FLUOXETINE; GABAPENTIN; LAMOTRIGINE; PREGABALIN; RECEPTOR INTERACTING PROTEIN 140; SEROTONIN UPTAKE INHIBITOR; TOPIRAMATE; TRAMADOL; TRICYCLIC ANTIDEPRESSANT AGENT;

DIABETES MELLITUS; DIABETIC NEUROPATHY; DISEASE CLASSIFICATION; DIZZINESS; ENDOTHELIAL DYSFUNCTION; HUMAN; NEUROPATHIC PAIN; PERIPHERAL NEUROPATHY; REVIEW; SENSORIMOTOR NEUROPATHY; SOMNOLENCE;

EID: 67249094514     PISSN: 15538036     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (7)

1. Partanen J, Niskanen L, Lehtinen J, et al. Natural history of peripheral neuropathy in patients with non-insulin-dependent diabetes mellitus. N Engl J Med 1995;333:89-94.
2. Tesfaye S, Chaturvedi N, Simon EM. Vascular risk factors and diabetic neuropathy. N Engl J Med 2005;352:341-350.
3. Rich J, Veves A. Forefoot and rearfoot plantar pressures in diabetic patients: Correlation to foot ulceration. WOUNDS 2000;12:82-87. (Pubitemid 33204440)
4. Pascoe MK, Low PA, Windebank AJ, Litchy WJ. Subacute diabetic proximal neuropathy. Mayo Clin Proc 1997;72:1123-1132. (Pubitemid 27528322)
5. Max MB, Lynch SA, Muir J, et al. Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy. N Engl J Med 1992;326:1250-1256.
6. Rosenstock J, Tuchman M, LaMoreaux L, Sharma U. Pregabalin for the treatment of painful diabetic peripheral neuropathy: A double-blind, placebo-controlled trial. Pain 2004;110:628-638. (Pubitemid 39036794)
7. Boulton AJ, Vinik AI, Arezzo JC, et al. Diabetic neuropathies: A statement by the American Diabetes Association. Diabetes Care 2005;28:956-962. (Pubitemid 40434506)